Year 2018 / Volume 110 / Number 4
Original
The safety of deep sedation with propofol controlled by the endoscopist in endoscopic retrograde cholangiopancreatography (ERCP): a prospective study in a tertiary hospital

217-222

DOI: 10.17235/reed.2018.5262/2017

Lara Luzón Solanas, Leticia Ollero Domenche, Eva María Sierra Moros, José Val Pérez, María Teresa Soria San Teodoro, Teresa Giménez Júlvez, Rafael Uribarrena Amezaga,

Abstract
Introduction: propofol administered by an endoscopist with a trained nurse has evolved as an alternative to anesthesia monitoring and is increasingly common in the routine clinical practice, even in advanced endoscopy. Objective: to evaluate the safety of deep sedation with endoscopist-controlled propofol in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP). Material and methods: this was a prospective study in patients undergoing ERCP under deep sedation with propofol. Different patient-related variables were included and the initial and final data on oxygen saturation (SatO2), blood pressure (BP) and heart rate (HR) were recorded in order to determine the presence of adverse events due to sedation (hypoxemia, hypotension, or bradycardia). Results: a total of 661 patients underwent ERCP under sedation with propofol over a 24-month period. The rate of recorded adverse events was 9.7%. The most frequent adverse event was hypoxemia (5.7%), followed by bradycardia (2.4%) and hypotension (1.6%). According to the univariate analysis, the occurrence of adverse events due to sedation (AES) was associated with an ASA score ≥ III (p = 0.026), older patients (p = 0.009), higher body mass index (BMI) (p = 0.002) and a longer exploration time (p = 0.034). The induction dose of propofol was also associated with a greater likelihood of adverse events (p = 0.045) but not the total dose of propofol administered (p = 0.153). According to the multivariate logistic regression analysis, age, body mass index (BMI) and the duration of the exploration were independent predictors of SAE (p < 0.05). Conclusion: deep sedation with propofol controlled by trained endoscopy staff is a safe method in complex endoscopic procedures such as ERCP.
Share Button
New comment
Comments
No comments for this article
References
1. Igea F, Casellas JA, González-Huix F, et al. Sedación en endoscopia digestiva. Guía de práctica clínica de la Sociedad Española de Endoscopia Digestiva. 2014; 106 :195–211.
2. Garewal D, Waikar P. Propofol sedation for ERCP procedures: a dilemna? Observations from an anesthesia perspective. Diagn. Ther. Endosc. 2012; 2012:639190.
3. Paulo S. Sedation in gastrointestinal endoscopy : a prospective study comparing nonanesthesiologist-administered propofol and monitored anesthesia care. 2015:7–13.
4. Bo LL, Bai Y, Bian J-J, Wen P-S, Li J-B, Deng X-M. Propofol vs traditional sedative agents for endoscopic retrograde cholangiopancreatography: a meta-analysis. World J. Gastroenterol. 2011; 17(30):3538–43.
5. Cheriyan DG, Byrne MF. Propofol use in endoscopic retrograde cholangiopancreatography and endoscopic ultrasound. World J. Gastroenterol. 2014; 20(18):5171–6.
6. Chainaki IG, Manolaraki MM, Paspatis G a. Deep sedation for endoscopic retrograde cholangiopacreatography. World J. Gastrointest. Endosc. 2011; 3(2):34–9.
7. Burtea DE, Dimitriu A, Maloş AE, Săftoiu A. Current role of non-anesthesiologist administered propofol sedation in advanced interventional endoscopy. World J. Gastrointest. Endosc. 2015; 7(10):981–6.
8. Coté G a, Hovis RM, Ansstas M a, et al. Incidence of sedation-related complications with propofol use during advanced endoscopic procedures. Clin. Gastroenterol. Hepatol. 2010; 8(2):137–42.
9. Yang JF, Farooq P, Zwilling K, Patel D, Siddiqui A a. Efficacy and Safety of Propofol-Mediated Sedation for Outpatient Endoscopic Retrograde Cholangiopancreatography (ERCP). Dig. Dis. Sci. 2016; 61(6):1686–91.
10. Riphaus A, Stergiou N, Wehrmann T. Sedation with propofol for routine ERCP in high-risk octogenarians: a randomized, controlled study. Am. J. Gastroenterol. 2005; 100(9):1957–63.
11. Riphaus A, Beilenhoff U, Vilmann P, et al. European Curriculum for Sedation Training in Gastrointestinal Endoscopy : Position Statement of the European Society of Gastrointestinal Endoscopy ( ESGE ) and European Society of Gastroenterology and Endoscopy Nurses and Associates ( ESGENA ). 2013:496–504.
12. Dumonceau Jean-marc et al. Non-anesthesiologist administration of propofol for gastrointestinal endoscopy : European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates Guideline – Updated June. Endoscopy 2015; 47: 1175-1189.
13. Triantafillidis JK, Merikas E, Nikolakis D, Papalois AE. Sedation in gastrointestinal endoscopy: current issues. World J. Gastroenterol. 2013; 19(4):463–81.
14. Nonaka M, Gotoda T, Kusano C, Fukuzawa M, Itoi T, Moriyasu F. Safety of Gastroenterologist-Guided Sedation with Propofol for Upper Gastrointestinal Therapeutic Endoscopy in Elderly Patients Compared with Younger Patients. Gut and liver. 2015; 9(1):38–42.
15. Qadeer MA, Vargo JJ, Khandwala F, Lopez R, Zuccaro G. Propofol versus traditional sedative agents for gastrointestinal endoscopy: a meta-analisis. Clin Gastroenterol Hepatol. 2005 Nov; 3(11):1049-56.
16. Wang D, Chen C, Chen J, et al. The use of propofol as a sedative agent in gastrointestinal endoscopy: a meta-analysis. PLoS One. 2013; 8(1):e53311.
17. Lichtenstein DR, Jagannath S, Baron TH, et al. Sedation and anesthesia in GI endoscopy. Gastrointest. Endosc. 2008; 68 (5):815–26.
18. Pérez-Cuadrado-Robles E, González-Ramírez A, Lancho-Seco Á, et al. Safety and risk factors for difficult endoscopist-directed ERCP sedation in daily practice : a hospital-based case-control study. 2016; 108:240–245.
19. Sethi S, Wadhwa V, Thaker A, et al. Propofol versus traditional sedative agents for advanced endoscopic procedures: a meta-analysis.Dig Endosc. 2014 Jul; 26(4):515-24.
20. Wehrmann T, Riphaus A. Sedation with propofol for interventional endoscopic procedures: A risk factor analysis. Scand. J. Gastroenterol. 2009; 43(3):368–374.
Related articles

Letter

Acute cholecystitis treated by direct visualization endoscopy

DOI: 10.17235/reed.2023.9432/2022

Editorial

Fewer endoscopists should perform more ERCPs

DOI: 10.17235/reed.2023.9507/2022

Letter

ERCP and situs inversus

DOI: 10.17235/reed.2021.8374/2021

Letter

Ischemic gastritis and severe diabetic ketoacidosis

DOI: 10.17235/reed.2020.7655/2020

Letter

Hemorrhagic complications following paracentesis

DOI: 10.17235/reed.2020.6914/2020

Digestive Diseases Image

A rare case of acute obstructive suppurative pancreatic ductitis associated with ERCP

DOI: 10.17235/reed.2018.5756/2018

Editorial

Pancreatic stents in ERCP. Where are we?

DOI: 10.17235/reed.2018.5670/2018

Special Article

Endoscopy and sedation: an inseparable binomial for the gastroenterologist

DOI: 10.17235/reed.2018.5585/2018

Letter to the Editor

Me, the intruder: revisited and rethought

DOI: 10.17235/reed.2018.5575/2018

Letter

Obstructive jaundice secondary to a hepatic hydatid cyst

DOI: 10.17235/reed.2018.5574/2018

Editorial

Pursuing excellence in ERCP

DOI: 10.17235/reed.2018.5373/2017

Letter to the Editor

A post-endoscopic retrograde cholangiopancreatography subcapsular hepatic hematoma

DOI: 10.17235/reed.2017.5123/2017

Letter to the Editor

Propofol sedation Quality and safety. Failure mode and effects analysis.

DOI: 10.17235/reed.2017.4976/2017

Letter to the Editor

Enough discussions about who should use propofol in gastrointestinal endoscopy

DOI: 10.17235/reed.2017.4901/2017

Original

Usefulness of an intra-gastric balloon before bariatric surgery

DOI: 10.17235/reed.2017.4624/2016

Special Article

Patient safety under deep sedation for digestive endoscopic procedures

DOI: 10.17235/reed.2016.4572/2016

Letter to the Editor

Accuracy of ASGE criteria for the prediction of choledocholithiasis

DOI: 10.17235/reed.2017.4511/2016

Original

Multicenter study on the safety of bariatric endoscopy

DOI: 10.17235/reed.2017.4499/2016

Letter to the Editor

Intramural gastric hematoma in the context of an acute pancreatitis

DOI: 10.17235/reed.2017.4494/2016

Case Report

Hepatic hematoma after ERCP: two new case reports

DOI: 10.17235/reed.2017.4237/2016

Digestive Diseases Image

Successive breaks in biliary stents

Citation tools
Luzón Solanas L, Ollero Domenche L, Sierra Moros E, Val Pérez J, Soria San Teodoro M, Giménez Júlvez T, et all. The safety of deep sedation with propofol controlled by the endoscopist in endoscopic retrograde cholangiopancreatography (ERCP): a prospective study in a tertiary hospital. 5262/2017


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 422 visits.
This article has been downloaded 422 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 15/09/2017

Accepted: 02/01/2018

Online First: 09/02/2018

Published: 02/04/2018

Article revision time: 103 days

Article Online First time: 147 days

Article editing time: 199 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology